{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:56:08Z","timestamp":1790873768926,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1124\/dmd.120.000188","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T04:45:14Z","timestamp":1598503514000},"page":"1113-1120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites"],"prefix":"10.1016","volume":"48","author":[{"given":"Brian D.","family":"Chapron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean C.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Toren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-1893","authenticated-orcid":false,"given":"Andrea","family":"Gaedigk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Steven","family":"Leeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.120.000188_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/070674379303800116","article-title":"Possible interaction between fluoxetine and pimozide causing sinus bradycardia","volume":"38","author":"Ahmed","year":"1993","journal-title":"Can J Psychiatry"},{"key":"10.1124\/dmd.120.000188_bib2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.clinthera.2005.07.013","article-title":"Coadministration of sertraline with cisapride or pimozide: an open-label, nonrandomized examination of pharmacokinetics and corrected QT intervals in healthy adult volunteers","volume":"27","author":"Alderman","year":"2005","journal-title":"Clin Ther"},{"key":"10.1124\/dmd.120.000188_bib3","first-page":"239","article-title":"[Absorption, metabolism and excretion of pimozide in man]","volume":"63","author":"Baro","year":"1972","journal-title":"Clin Ter"},{"key":"10.1124\/dmd.120.000188_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psym.2012.11.001","article-title":"QTc prolongation, torsades de pointes, and psychotropic medications","volume":"54","author":"Beach","year":"2013","journal-title":"Psychosomatics"},{"key":"10.1124\/dmd.120.000188_bib5","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/dmd.118.080952","article-title":"Hepatic abundance and activity of androgen- and drug-metabolizing enzyme UGT2B17 are associated with genotype, age, and sex","volume":"46","author":"Bhatt","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000188_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/cpt.819","article-title":"Critical issues and optimized practices in quantification of protein abundance level to determine interindividual variability in DMET proteins by LC-MS\/MS proteomics","volume":"103","author":"Bhatt","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.000188_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cts.12692","article-title":"Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the clinical pharmacogenetics implementation consortium and Dutch pharmacogenetics working group","volume":"13","author":"Caudle","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1124\/dmd.120.000188_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0009-9236(99)70117-7","article-title":"Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)","volume":"65","author":"Desta","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.000188_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3565(24)37449-X","article-title":"Identification and characterization of human cytochrome P450 isoforms interacting with pimozide","volume":"285","author":"Desta","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.120.000188_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00004714-200204000-00009","article-title":"In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin","volume":"22","author":"Desta","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.120.000188_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/107424840100600306","article-title":"Pimozide (Orap) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current in native cardiac myocytes","volume":"6","author":"Drolet","year":"2001","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1124\/dmd.120.000188_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00004714-200006000-00005","article-title":"Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome","volume":"20","author":"Flockhart","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.120.000188_bib13","first-page":"232","article-title":"Metabolism of pimozide by CYF3A and CYP2D6 in human liver microsomes","volume":"61","author":"Flockhart","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.000188_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.clpt.1996.256","article-title":"A metabolic interaction between clarithromycin and pimozide may result in cardiac toxicity","volume":"59","author":"Flockhart","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.000188_bib15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10072-011-0678-1","article-title":"Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome","volume":"32","author":"Gulisano","year":"2011","journal-title":"Neurol Sci"},{"key":"10.1124\/dmd.120.000188_bib16","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2165\/00003495-200262110-00006","article-title":"Antipsychotic-related QTc prolongation, torsade de pointes and sudden death","volume":"62","author":"Haddad","year":"2002","journal-title":"Drugs"},{"key":"10.1124\/dmd.120.000188_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1389200023338017","article-title":"Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update","volume":"3","author":"Hemeryck","year":"2002","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.120.000188_bib18","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00004583-199409000-00022","article-title":"Paroxetine-pimozide drug interaction","volume":"33","author":"Horrigan","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1124\/dmd.120.000188_bib19","first-page":"1287","article-title":"Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series","volume":"25","author":"Janssen","year":"1975","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/dmd.120.000188_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1192\/bjp.144.6.625","article-title":"Within-individual variation in steady state plasma levels of different neuroleptics and prolactin","volume":"144","author":"McCreadie","year":"1984","journal-title":"Br J Psychiatry"},{"key":"10.1124\/dmd.120.000188_bib21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1520\/JFS14240J","article-title":"A fatality involving moclobemide, sertraline, and pimozide","volume":"42","author":"McIntyre","year":"1997","journal-title":"J Forensic Sci"},{"key":"10.1124\/dmd.120.000188_bib22","series-title":"Annual Meeting of Population Approach Group in Europe","article-title":"Population pharmacokinetic modelling of pimozide and its relation to CYP2D6 genotype","author":"Nucci","year":"2007"},{"key":"10.1124\/dmd.120.000188_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-197612010-00001","article-title":"Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry","volume":"12","author":"Pinder","year":"1976","journal-title":"Drugs"},{"key":"10.1124\/dmd.120.000188_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpsychores.2008.03.006","article-title":"The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies","volume":"65","author":"Robertson","year":"2008","journal-title":"J Psychosom Res"},{"key":"10.1124\/dmd.120.000188_bib25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.4088\/JCP.11m07572","article-title":"CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration\u2019s new dosing recommendations","volume":"73","author":"Rogers","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/dmd.120.000188_bib26","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1093\/bioinformatics\/btq584","article-title":"The SMARTCyp cytochrome P450 metabolism prediction server","volume":"26","author":"Rydberg","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1124\/dmd.120.000188_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/cap.2016.0026","article-title":"Randomized, double-blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of tourette\u2019s disorder in children and adolescents","volume":"27","author":"Sallee","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1124\/dmd.120.000188_bib28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","article-title":"Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette\u2019s disorder","volume":"154","author":"Sallee","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1124\/dmd.120.000188_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archpsyc.1989.01810080052006","article-title":"Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette\u2019s syndrome","volume":"46","author":"Shapiro","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/dmd.120.000188_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/psp4.12170","article-title":"Database of optimized proteomic quantitative methods for human drug disposition-related proteins for applications in physiologically based pharmacokinetic modeling","volume":"6","author":"Vrana","year":"2017","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/dmd.120.000188_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00787-010-0154-0","article-title":"Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders","volume":"20","author":"Yoo","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1124\/dmd.120.000188_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FTD.0b013e31815c16f5","article-title":"Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring","volume":"29","author":"Zhou","year":"2007","journal-title":"Ther Drug Monit"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.120.000188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:18:19Z","timestamp":1739956699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624077031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0090955624077031"],"URL":"https:\/\/doi.org\/10.1124\/dmd.120.000188","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.120.000188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}